Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bergman

Showing results (661-670 of 904) with videos related to

Pageof 91
Sort By:
Molecular Oncology|February 12, 2021
Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastasesTesa M Severson, Yanyun Zhu, Angelo M De Marzo, et al.
Gastrointestinal Endoscopy|December 28, 2020
Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility studyAnnieke C G van Baar, Suzanne Meiring, Paul Smeele, et al.
Cancer Research|December 21, 2006
Comparison of kinome profiles of Barrett's esophagus with normal squamous esophagus and normal gastric cardiaJantine W P M van Baal, Sander H Diks, Ronald J A Wanders, et al.
Endoscopy|January 31, 2014
Narrow band imaging does not reliably predict residual intestinal metaplasia after radiofrequency ablation at the neo-squamo columnar junctionLorenza Alvarez Herrero, Wouter L Curvers, Raf Bisschops, et al.
Gastrointestinal Endoscopy|March 26, 2019
Durability of radiofrequency ablation for treatment of esophageal squamous cell neoplasia: 5-year follow-up of a treated cohort in ChinaXinying Yu, Sanne N van Munster, Yueming Zhang, et al.
Digestive Diseases and Sciences|January 8, 2025
From Endoscopic Inspection to Gene-Expression: A Thorough Assessment of the Duodenal Mucosa After Resurfacing-A Prospective StudyS Meiring, Ö Aydin, A C G van Baar, et al.
Drugs & Aging|February 9, 2019
Age-Associated Hematological Toxicity in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel in Clinical PracticeMarie-Rose B S Crombag, Aurelia H M de Vries Schultink, Jacobine G C van Doremalen, et al.
BJU International|September 24, 2013
Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy aloneLaura S Mertens, Richard P Meijer, Wim Meinhardt, et al.
Oncotarget|December 8, 2017
The adaptive immune system promotes initiation of prostate carcinogenesis in a human c-Myc transgenic mouse modelMonique H M Melis, Ekaterina Nevedomskaya, Johan van Burgsteden, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
Predictors of Early Polymetastatic Relapse After SABR for up to 5 Oligometastases: A Secondary Analysis of the Phase II SABR-5 TrialSarah Baker, Benjamin Mou, Will Jiang, et al.
Pageof 91

Showing results (661-670 of 904) with videos related to

Sort By:
Pageof 91
Molecular Oncology|February 12, 2021
Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastasesTesa M Severson, Yanyun Zhu, Angelo M De Marzo, et al.
Gastrointestinal Endoscopy|December 28, 2020
Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility studyAnnieke C G van Baar, Suzanne Meiring, Paul Smeele, et al.
Cancer Research|December 21, 2006
Comparison of kinome profiles of Barrett's esophagus with normal squamous esophagus and normal gastric cardiaJantine W P M van Baal, Sander H Diks, Ronald J A Wanders, et al.
Endoscopy|January 31, 2014
Narrow band imaging does not reliably predict residual intestinal metaplasia after radiofrequency ablation at the neo-squamo columnar junctionLorenza Alvarez Herrero, Wouter L Curvers, Raf Bisschops, et al.
Gastrointestinal Endoscopy|March 26, 2019
Durability of radiofrequency ablation for treatment of esophageal squamous cell neoplasia: 5-year follow-up of a treated cohort in ChinaXinying Yu, Sanne N van Munster, Yueming Zhang, et al.
Digestive Diseases and Sciences|January 8, 2025
From Endoscopic Inspection to Gene-Expression: A Thorough Assessment of the Duodenal Mucosa After Resurfacing-A Prospective StudyS Meiring, Ö Aydin, A C G van Baar, et al.
Drugs & Aging|February 9, 2019
Age-Associated Hematological Toxicity in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel in Clinical PracticeMarie-Rose B S Crombag, Aurelia H M de Vries Schultink, Jacobine G C van Doremalen, et al.
BJU International|September 24, 2013
Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy aloneLaura S Mertens, Richard P Meijer, Wim Meinhardt, et al.
Oncotarget|December 8, 2017
The adaptive immune system promotes initiation of prostate carcinogenesis in a human c-Myc transgenic mouse modelMonique H M Melis, Ekaterina Nevedomskaya, Johan van Burgsteden, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
Predictors of Early Polymetastatic Relapse After SABR for up to 5 Oligometastases: A Secondary Analysis of the Phase II SABR-5 TrialSarah Baker, Benjamin Mou, Will Jiang, et al.
Pageof 91